Cognis' DSX 3291 - ultra-efficient VOC-free rheology modifier for "green" water-based architectural coatings
The latest addition to Cognis rheology series is DSX 3291, a highly efficient innovative associative thickener for "green" water-based architectural coatings. It is an excellent pseudoplastic viscosity builder which is up to five times more efficient than conventional associative thickener products. DSX 3291 is easy to handle and can be incorporated into coating formulations with low shear mixing. Furthermore, the product provides superior sag and chemical resistance, excellent anti-settling properties, low viscosity drop on tinting and allows thick coatings to be easily sprayed. DSX 3291 is suitable for all types of paints, such as premium flat and eggshell, semi-gloss and gloss architectural coatings and industrial paints.
State-of-the-art in building strong pseudoplasticity
Based on polyurethane chemistry, the product is free from harmful volatile organic compounds (VOCs) and alkylphenol ethoxylates (APEOs), does not contain heavy metals (such as organic tin compounds) and is odor free. DSX 3291 is fully in line with the "green" trend and complies with the latest environmental regulations.
"With DSX 3291, we have developed an extremely efficient pseudoplastic rheology modifier at the cutting edge of technology," says Shailesh Shah, Director Global Marketing Coatings. "Users are increasingly demanding environmentally sound solutions without compromising on performance or quality. DSX 3291 gives paint manufacturers a competitive advantage as it offers a unique combination of extreme efficiency in building low shear viscosity with an easy-to-incorporate behavior and 'green' features."
BASF Personal Care and Nutrition GmbH
Cognis is a worldwide supplier of innovative specialty chemicals and nutritional ingredients, with a particular focus on the areas of wellness and sustainability. The company employs about 5,900 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, as well as agriculture and mining.
Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2008, Cognis recorded sales of about 3 billion euros and an Adjusted EBITDA (operating result) of 351 million euros.
Press releases you might also be interested in
Weitere Informationen zum Thema "Medizintechnik":
Intel zeigt Ausblick auf die künstliche Intelligenz von morgen
Welche Veränderungen, die künstliche Intelligenz zukünftig für uns alle bringen wird, konnte man in diesem Jahr auf der größten Konsumenten-Elektronikmesse der Welt, der CES in Las Vegas sehen. Auch am Stand von Intel gab es vieles zu sehen. Angefangen vom Autonomen Fahren, bis hin zu den Möglichkeiten, die die Virtuelle Realität bietetWeiterlesen